Corcept Therapeutics
CORT
#2078
Rank
$9.07 B
Marketcap
$86.10
Share price
1.71%
Change (1 day)
41.67%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of September 2025 : $6.35 Million USD

According to Corcept Therapeutics 's latest financial reports the company's total debt is $6.35 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$6.93 M4493.38%
2023-12-31$0.15 M-86.79%
2022-12-31$1.14 M117.3%
2021-12-31$0.52 M-79.38%
2020-12-31$2.55 M-26.29%
2019-12-31$3.46 M
2018-12-31N/A
2016-12-31$14.66 M-2.01%
2015-12-31$14.96 M58.8%
2014-12-31$9.42 M64.1%
2013-12-31$5.74 M116.72%
2012-12-31$2.65 M
2010-12-31N/A-100%
2009-12-31$0 M-62.5%
2008-12-31$0.01 M-44.83%
2007-12-31$0.02 M-30.95%
2006-12-31$0.04 M-22.22%
2005-12-31$0.05 M
2003-12-31$0.52 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
$45.79 B 720,173.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$51.04 B 802,683.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$32.02 B 503,548.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
$42.50 B 668,453.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$60.84 B 956,930.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$41.37 B 650,639.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.30 B 4,725.34%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
$0.11 B 1,785.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.60 B 9,403.63%๐Ÿ‡บ๐Ÿ‡ธ USA